Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
Kopala
L
L
Honer
W G
WG
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016666:Fluvoxamine / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D011985:Receptors, Serotonin / Q000187:drug effects; D018967:Risperidone; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012701:Serotonin / Q000502:physiology*
D014150:Antipsychotic Agents; D007555:Isoxazoles; D010880:Piperidines; D011985:Receptors, Serotonin; D012701:Serotonin; D018967:Risperidone; D016666:Fluvoxamine